comparemela.com

Enzene Romiplostim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Enzene Biosciences Announced Romiplostim Approval in India | Goodwin

Enzene Biosciences Announced Romiplostim Approval in India | Goodwin
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

Enzene obtains marketing authorisation for Romiplostim Biosimilar drug in India

Enzene Biosciences Ltd obtains Marketing Authorization for its Romiplostim Biosimilar drug in India

Pune (Maharashtra) [India], August 20 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its second biosimilar drug "Romiplostim", indicated for the treatment of chronic Immune Thrombocytopenic Purpura (ITP) in adults.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.